GENE ONLINE|News &
Opinion
Blog

Gilead Sciences
Gilead Sciences Acquires CymaBay for $4.3 billion, Heralding a New Era in PBC Treatment
2024-02-15
FDA Boxed Warning for CAR-T therapy, Affecting Bristol-Myers Squibb, Novartis, Janssen, Gilead Sciences
2024-01-24
GILEAD LAUNCHES GLOBAL ALL4LIVER GRANT PROGRAM TO HELP ACHIEVE THE WORLD HEALTH ORGANIZATION’S GOAL OF VIRAL HEPATITIS ELIMINATION BY 2030
2023-07-28
Gilead’s HDV Drug Headed Towards European Approval Even With FDA Rejection
2023-05-08
GILEAD TO PRESENT DATA AT APASL 2023 ON EFFECTIVE MODELS FOR MONITORING AND TREATING HEPATITIS C AND EFFICACY OF ANTIVIRAL TREATMENTS FOR HIV-1 AND HBV-COINFECTED ADULTS
2023-02-14
Jounce Sells Anti-CCR8 Antibody to Gilead, Forgoing $645 Million In Milestones
2022-12-28
Gilead, Arcus’ Anti-TIGIT Combinations Show Survival Advantage Over Anti-PD1 Monotherapy In Phase 2 Trial
2022-12-20
The FDA Expands Use for Gilead Science’s HBV Treatment
2022-11-02
Gilead Touts Long-Term Efficacy And Safety Data For HIV Drug
2022-10-26
Kite to Use Refuge’s Gene Expression Platform for New CAR-T Therapies
2022-10-21
Gilead and MacroGenics Strike Potential $1.7 billion Collaboration Over Bispecific Antibodies
2022-10-17
Action Date Set for Gilead Sciences’ HR+/HER2- breast cancer sBLA
2022-10-11
CHMP Gives Kite’s Lymphoma Immunotherapy a Positive Opinion
2022-09-16
Gilead’s Novel Capsid Inhibitor Treatment for HIV Gains First Approval from European Commission
2022-08-22
Gilead Forking Over $280 million to Everest to Regain Rights to Breast Cancer Treatment
2022-08-16
1 2 3 5
LATEST
Crossing Borders for a New Era in Healthcare Quality: Highlights from the 1st Asia Pacific Forum on Healthcare Quality
2024-12-12
Precision Medicine in Breast & Lung Cancer: Coordinated Diagnostics and Treatment Approaches for Personalized Care
2024-12-12
Fighting the Good Fight: Global Experts Unite to Share Oncology Breakthroughs at Asia-Pacific Precision Cancer Treatment Forum
2024-12-12
AI-Powered Blood Test Achieves 98% Accuracy in Early Breast Cancer Detection
2024-12-11
Taiwan’s Vice President Hsiao Bi-Khim Advocates Innovations in Medtech, Biotech, and Healthtech
2024-12-11
Six Game-Changing Cancer Treatments Built for Unstoppable Growth in 2025 – Part II
2024-12-11
Six Game-Changing Cancer Treatments Built for Unstoppable Growth in 2025 – Part I
2024-12-11
EVENT
Scroll to Top